Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

Completed · Phase 4

Conditions studied: Myopia

In brief

To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.

Key facts

Study ID

NCT00627302

Run by

Bp Consulting, Inc

People needed

40

Starts

2008-02-01

Expected to finish

2008-11-01

Last updated by the study team

2008-11-24

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males or females > 21 years old
• Scheduled to undergo bilateral LASIK
• Likely to complete all study visits and able to provide informed consent

You may not qualify if…

• Prior or current use of topical cyclosporine within the last 1 year
• Known contraindications to any study medication or ingredients
• Ocular disorders
• Active ocular diseases or uncontrolled systemic disease
• Active ocular allergies
• Complications at the time of surgery

Where it is running

• Ophthalmic Consultants of long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.